Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders

NCT ID: NCT06622993

Last Updated: 2024-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-31

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidemiological studies show that one person in eight suffers from at least one psychiatric disorder. Mental health is therefore a major public health issue, and care for these disorders must continue to be improved.

The management of mental disorders has long followed the traditional categorical approach of developing a treatment for a given disorder. However, researchers have recently pointed out the limits of this approach in the field of mental health. They highlight the large number of co-morbidities, the existence of aspecific disorders and the intra-diagnostic heterogeneity of patients. These factors have led them to develop a transdiagnostic approach, which focuses on the mechanisms common to the various disorders in order to treat them at the same time and thus reduce the cost of treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychiatric Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Programm SKILLS

Group Type EXPERIMENTAL

Psychotherapy

Intervention Type OTHER

The experimental group will receive the SKILLS program, i.e. 10 group psychotherapy sessions.

Waiting list

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychotherapy

The experimental group will receive the SKILLS program, i.e. 10 group psychotherapy sessions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female ≥ 18 years of age
* Have at least one diagnosis of a psychiatric disorder
* Be able to carry out psychotherapy sessions
* Have been on stable psychiatric medication for 30 days
* Written informed consent obtained from the participant
* Be affiliated to a social security scheme or equivalent

Exclusion Criteria

* Cognitive deficits marked by a score above the 10th percentile for one or more tests in the assessment history.
* Persons deprived of liberty by judicial or administrative decision; Persons under legal protection: guardianship or curatorship
* Presence of a severe depressive episode
* Be engaged in psychotherapeutic work elsewhere
* Presence of a state of excessive deficit, making psychotherapy impossible
* Presence of psychic decompensation (e.g. delusions) making psychotherapy impossible
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

VANCAPPEL

Role: CONTACT

+33247477111

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DR240057

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Skills for Wellness
NCT01980147 RECRUITING NA